Physician profile
Sarah Ellen E Stephens
NPI 1427342070
$6,728.86
in general payments reported to CMS, 2019-2025
45 companies · $1,412 in 2025
The $1,412 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $224 · 2021: $318 · 2022: $1,030 · 2023: $1,646 · 2024: $1,799 · 2025: $1,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,662 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,662.13 |
| Education | $194.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $918.37 | 2020-2025 | Dupixent |
| Glaxosmithkline, LLC. | $748.30 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Axsome Therapeutics, INC. | $582.18 | 2022-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $429.28 | 2019-2025 | |
| Genzyme Corporation | $422.98 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $342.78 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $262.98 | 2022-2025 | Glassia, Hyqvia |
| Amgen INC. | $254.27 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.03 | 2021-2025 | Ofev, Stiolto Respimat |
| Insmed, INC. | $243.55 | 2019-2025 | Arikayce |
| United Therapeutics Corporation | $233.33 | 2022-2025 | Tyvaso, Tyvaso |
| Pulmonx Corporation | $227.04 | 2023-2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Harmony Biosciences LLC | $208.72 | 2020-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $181.60 | 2024-2025 | Lumryz |
| Actelion Pharmaceuticals US, INC. | $155.71 | 2019-2024 | Opsumit, Uptravi |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $153.93 | 2022-2024 | Acthar |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Ani Pharmaceuticals, INC. | $94.00 | 2024-2025 | Purified Cortrophin Gel |
| Resmed Corp | $75.16 | 2023 | |
| Allergan, INC. | $72.58 | 2019-2020 | |
| Fisher & Paykel Healthcare INC | $67.95 | 2019-2023 | Fisher & Paykel Healthcare |
| Inspire Medical Systems, INC. | $66.29 | 2023-2024 | Inspire |
| Electromed, INC. | $61.56 | 2022-2024 | Smartvest |
| Idorsia Pharmaceuticals US INC | $50.08 | 2023-2025 | Quviviq, Quviviq |
| Grifols USA, LLC | $46.84 | 2023 | Prolastin-C Liquid |
| Arbor Pharmaceuticals, INC. | $46.65 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $46.12 | 2020-2025 | Zerbaxa, Keytruda |
| Tetraphase Pharmaceuticals, INC. | $45.62 | 2019 | |
| Chiesi USA, INC. | $26.66 | 2023 | Curosurf |
| Vifor Pharma, INC. | $26.06 | 2025 | Zemaira |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.24 | 2023 | Lifevest |
| Verona Pharma, INC. | $24.09 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $23.85 | 2023 | Yupelri |
| Baxter Healthcare | $23.73 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $21.20 | 2019 | |
| Ambu INC. | $21.15 | 2023 | |
| Haemonetics Corporation | $19.76 | 2024 | Teg6s Hemostasis System |
| Inari Medical, INC. | $19.48 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Advanced Respiratory, INC | $18.10 | 2021 | |
| Pfizer INC. | $17.90 | 2022 | |
| Abbvie INC. | $17.19 | 2021 | |
| Biogen, INC. | $16.00 | 2021 | |
| Apria Healthcare LLC | $14.18 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ellen Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.